Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
16049 | 609 | 34.0 | 59% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
994 | 9968 | IDIOPATHIC PULMONARY FIBROSIS//USUAL INTERSTITIAL PNEUMONIA//PULMONARY ALVEOLAR PROTEINOSIS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PULMONARY RHEUMATOID NODULE | Author keyword | 4 | 75% | 0% | 3 |
2 | RHEUMATOID LUNG | Author keyword | 4 | 75% | 0% | 3 |
3 | RHEUMATOID PLEURITIS | Author keyword | 4 | 75% | 0% | 3 |
4 | LE CELLS | Author keyword | 3 | 50% | 1% | 4 |
5 | NODULOSIS | Author keyword | 2 | 44% | 1% | 4 |
6 | PULMONARY RHEUMATOID NODULES | Author keyword | 2 | 67% | 0% | 2 |
7 | COLLAGEN VASCULAR DISEASES | Author keyword | 2 | 19% | 1% | 8 |
8 | ANTI CYCLIC CITRULLINATED ANTIBODIES | Author keyword | 1 | 50% | 0% | 2 |
9 | TART CELLS | Author keyword | 1 | 100% | 0% | 2 |
10 | CAPLANS SYNDROME | Author keyword | 1 | 40% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PULMONARY RHEUMATOID NODULE | 4 | 75% | 0% | 3 | Search PULMONARY+RHEUMATOID+NODULE | Search PULMONARY+RHEUMATOID+NODULE |
2 | RHEUMATOID LUNG | 4 | 75% | 0% | 3 | Search RHEUMATOID+LUNG | Search RHEUMATOID+LUNG |
3 | RHEUMATOID PLEURITIS | 4 | 75% | 0% | 3 | Search RHEUMATOID+PLEURITIS | Search RHEUMATOID+PLEURITIS |
4 | LE CELLS | 3 | 50% | 1% | 4 | Search LE+CELLS | Search LE+CELLS |
5 | NODULOSIS | 2 | 44% | 1% | 4 | Search NODULOSIS | Search NODULOSIS |
6 | PULMONARY RHEUMATOID NODULES | 2 | 67% | 0% | 2 | Search PULMONARY+RHEUMATOID+NODULES | Search PULMONARY+RHEUMATOID+NODULES |
7 | COLLAGEN VASCULAR DISEASES | 2 | 19% | 1% | 8 | Search COLLAGEN+VASCULAR+DISEASES | Search COLLAGEN+VASCULAR+DISEASES |
8 | ANTI CYCLIC CITRULLINATED ANTIBODIES | 1 | 50% | 0% | 2 | Search ANTI+CYCLIC+CITRULLINATED+ANTIBODIES | Search ANTI+CYCLIC+CITRULLINATED+ANTIBODIES |
9 | TART CELLS | 1 | 100% | 0% | 2 | Search TART+CELLS | Search TART+CELLS |
10 | CAPLANS SYNDROME | 1 | 40% | 0% | 2 | Search CAPLANS+SYNDROME | Search CAPLANS+SYNDROME |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | METHOTREXATE PNEUMONITIS | 8 | 50% | 2% | 12 |
2 | EXTRAARTICULAR MANIFESTATIONS | 7 | 23% | 4% | 26 |
3 | ACCELERATED NODULOSIS | 6 | 31% | 2% | 15 |
4 | NONSMOKING PATIENTS | 6 | 100% | 1% | 4 |
5 | SMALL AIRWAYS FUNCTION | 4 | 67% | 1% | 4 |
6 | COLLAGEN VASCULAR DISEASES | 4 | 17% | 3% | 20 |
7 | FIBROSING ALVEOLITIS | 4 | 11% | 5% | 30 |
8 | COLLAGEN VASCULAR DISEASE | 3 | 17% | 3% | 17 |
9 | HRCT FINDINGS | 3 | 50% | 1% | 4 |
10 | METHOTREXATE INDUCED PNEUMONITIS | 2 | 28% | 1% | 5 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
PULMONARY INVOLVEMENT IN RHEUMATOID-ARTHRITIS | 1995 | 109 | 57 | 56% |
Interstitial Lung Disease Induced or Exacerbated by TNF-Targeted Therapies: Analysis of 122 Cases | 2011 | 52 | 44 | 27% |
Pulmonary manifestations of rheumatoid arthritis | 1998 | 52 | 87 | 51% |
Predictors of mortality in rheumatoid arthritis-related interstitial lung disease | 2014 | 6 | 26 | 42% |
Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: A systematic literature review | 2014 | 9 | 96 | 31% |
Lung disease in rheumatoid arthritis | 2008 | 33 | 56 | 43% |
Interstitial Lung Disease in Patients with Rheumatoid Arthritis: Spontaneous and Drug Induced | 2014 | 2 | 69 | 61% |
Rheumatoid Arthritis (RA) associated interstitial lung disease (ILD) | 2013 | 4 | 80 | 45% |
Lung involvement and drug-induced lung disease in patients with rheumatoid arthritis | 2013 | 4 | 71 | 41% |
Occurrence of pulmonary rheumatoid nodules following biological therapies | 2015 | 0 | 6 | 83% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AUTOIMMUNE INTERSTITIAL LUNG DIS PROGRAM | 1 | 50% | 0.2% | 1 |
2 | CLIN PHYS MED REHABIL 2 | 1 | 50% | 0.2% | 1 |
3 | CLIN RADIOL IMAGING | 1 | 50% | 0.2% | 1 |
4 | HPRHEUMATOL B | 1 | 50% | 0.2% | 1 |
5 | NACL ENFERMEDADES P CIRUGIA TORAC | 1 | 50% | 0.2% | 1 |
6 | PROGRAMA BECARIOS INVEST | 1 | 50% | 0.2% | 1 |
7 | PROGRAMA INT MED | 1 | 50% | 0.2% | 1 |
8 | PROGRAMA MAESTRIA CIENCIAS MED | 1 | 50% | 0.2% | 1 |
9 | PROGRAMA SERV SOCIAL INVEST | 1 | 50% | 0.2% | 1 |
10 | RHEUMATOLMEYERS PRIMARY CARE | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000265403 | SHRINKING LUNG SYNDROME//IDIOPATHIC PULMONARY HEMOSIDEROSIS//PULMONARY HEMOSIDEROSIS |
2 | 0.0000245713 | BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA//CRYPTOGENIC ORGANIZING PNEUMONIA//ORGANIZING PNEUMONIA |
3 | 0.0000201434 | RHEUMATOID VASCULITIS//RHEUMATOID MYOSITIS//EXTRAARTICULAR MANIFESTATIONS |
4 | 0.0000137302 | IDIOPATHIC PULMONARY FIBROSIS//USUAL INTERSTITIAL PNEUMONIA//IDIOPATHIC INTERSTITIAL PNEUMONIA |
5 | 0.0000130727 | CRICOARYTENOID ARTHRITIS//LARYNGEAL SARCOIDOSIS//SINONASAL SARCOIDOSIS |
6 | 0.0000125968 | CHRONIC EOSINOPHILIC PNEUMONIA//ACUTE EOSINOPHILIC PNEUMONIA//EOSINOPHILIC PNEUMONIA |
7 | 0.0000108149 | METHOTREXATE//METHOTREXATE POLYGLUTAMATES//MX 68 |
8 | 0.0000106796 | PULMONARY TOXICITY//PULM DIS INTENS CARE//GEFITINIB IRESSA |
9 | 0.0000090067 | GRANULOMA ANNULARE//NECROBIOSIS LIPOIDICA//SUBCUTANEOUS GRANULOMA ANNULARE |
10 | 0.0000085079 | KL 6//KREBS VON DEN LUNGEN 6//BIOLOGICAL DISEASE MODIFYING ANTIRHEUMATIC DRUG |